Compliance updated on Sep 10, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Nuwellis Inc

NUWE ✓ COMPLIANTFree checks used up today ☆ Track — members

NASDAQ · Healthcare · Advanced Medical Equipment & Technology ·

USA Micro Cap Analyst: N/A

Last Close

$0.83

▼ -5.44%

Market Cap $3.01M · Vol 29.75K

Price charts are for members

Interactive price history from intraday to 5 years, on every stock and ETF.

See plans

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$3.01M

Micro Cap

Div Yield

N/A

EPS Growth

N/A

YoY

RSI (14)

54.52

Momentum

Beta

0.10

vs Market

52W High

$172.55

99.52% below

52W Low

$0.72

15.41% above

Volume

29.75K

Avg 129.31K

P/B

1.12

Price-to-book

ROE

N/A

Return on equity

Free Float

95.04%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Nuwellis Inc (NUWE) stock is Shariah compliant

You’ve used your 10 free compliance checks today

Choose a plan

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share.Members see the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does NUWE pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-2.20%

-28.77%

-81.84%

-97.71%

YTD

-98.64%

-99.35%

-100.00%

Financials & Valuation

TTM · Annual

Total Revenue	$8.27M
Net Income	$-17,521,000.00
Revenue Growth (YoY)	+14.14%
Gross Margin	61.96%
Operating Margin	-134.29%
Net Profit Margin	-211.86%
ROE	N/A
ROA · ROIC	-219.20% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	0.15
P/B	1.12
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	3.65M

Technical Indicators

50-Day SMA	$1.52
200-Day SMA	$36.98
RSI (14)	54.52
Beta	0.10
52-Week High	$172.55
52-Week Low	$0.72

Volume Today	29.75K
Avg Daily Volume (30D)	129.31K
Relative Volume	0.23x
Volatility (10D)	182.75
Volatility (30D)	127.56
Free Float	95.04%

Analyst Consensus

N/A

Current Price $0.83

Mean Target N/A

52W Low$0.72 52W High$172.55

Current

Target

$0.72 $172.55

Current Analyst target

· 0 analysts

Identifiers

ExchangeNASDAQ

FIGIBBG001SNT6T0

ISINUS67113Y8012

CountryUSA

Sub-IndustryAdvanced Medical Equipment & Technology (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

TMO Thermo Fisher Scientific Inc -0.04% DHR Danaher Corporation +2.43% ISRG Intuitive Surgical, Inc. +0.11% BSX Boston Scientific Corp +2.74% EW Edwards Lifesciences Corporation +0.50%

Company Profile

Nuwellis, Inc. is a commercial-stage medical technology company. The Company is focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems (collectively the Aquadex System). The Aquadex SmartFlow system is indicated for temporary or extended use in adult and pediatric patients weighing 20 kilograms or more whose fluid overload is unresponsive to medical management, including diuretics. The Aquadex System is designed to remove excess fluid from patients suffering from fluid overload who have failed diuretic therapy. The Aquadex System consists of a console, which is a piece of equipment containing electromechanical pumps and a liquid crystal display (LCD) screen; a one-time disposable blood circuit set, which is an integrated collection of tubing, filters, sensors, and connectors that contain and deliver the blood from and back to the patient, and a disposable catheter.